ストックスクリーナーアプリを入手
1.13
1.36%
0.025
前日終値:
$1.105
開ける：
$1.09
24時間の取引高:
18,288
Relative Volume:
0.24
時価総額：
$9.74M
収益：
$6.74M
当期純損益:
$-14.74M
株価収益率:
-0.5024
EPS:
-2.2491
ネットキャッシュフロー:
$-18.31M
1週間 パフォーマンス:
-0.88%
1か月 パフォーマンス:
+2.75%
6か月 パフォーマンス:
-24.83%
1年 パフォーマンス:
-32.53%
1日の値動き範囲:
$1.09
$1.14
1週間の範囲:
$1.09
$1.21
52週間の値動き範囲:
$0.93
$2.42
Evogene Ltd Stock (EVGN) Company Profile
EVGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.118 | 9.63M | 6.74M | -14.74M | -18.31M | -2.2491 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.18 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.20 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.42 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
796.94 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
338.52 | 35.45B | 4.98B | 69.59M | 525.67M | 0.5197 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-08 | 開始されました | ROTH Capital | Buy |
| 2021-07-29 | 開始されました | Aegis Capital | Buy |
| 2020-12-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2013-12-16 | 開始されました | Oppenheimer | Outperform |
Evogene Ltd (EVGN) 最新ニュース
Is Evogene Ltd. stock undervalued vs historical averages2025 Buyback Activity & Weekly Watchlist for Hot Stocks - ulpravda.ru
Why Evogene Ltd. stock appeals to dividend seekers2025 EndofYear Setup & Real-Time Volume Spike Alerts - ulpravda.ru
Is Evogene Ltd. stock attractive for growth ETFsQuarterly Earnings Summary & Daily Entry Point Trade Alerts - ulpravda.ru
Will Evogene Ltd. stock remain a Wall Street favoriteJuly 2025 Reactions & Weekly High Return Opportunities - ulpravda.ru
Is Evogene Ltd. stock attractive for hedge fundsWeekly Trade Summary & AI Driven Price Predictions - ulpravda.ru
Evogene, Unravel Biosciences announce scientific collaboration - TipRanks
How Evogene Ltd. stock compares to industry benchmarksInterest Rate Changes & Affordable Portfolio Growth - ulpravda.ru
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders - Chartmill
Evogene (NASDAQ:EVGN) Stock Passes Below Fifty Day Moving Average – Time to Sell? - Defense World
Panic Selling: Will Evogene Ltd stock remain a Wall Street favorite2025 Price Targets & Low Drawdown Trading Strategies - moha.gov.vn
Evogene Appoints Dr. Olga Nissan as Vice President of Business Development to Drive AI-Driven Growth - The Globe and Mail
Evogene appoints Dr. Olga Nissan as VP of business development By Investing.com - Investing.com Nigeria
Evogene appoints Nissan as VP of Business Development - TipRanks
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development - Finviz
Evogene appoints Dr. Olga Nissan as VP of business development - Investing.com
Is Evogene Ltd. stock resilient to inflationJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Will Evogene Ltd. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & AI Based Trade Execution Alerts - DonanımHaber
Can Evogene Ltd. stock sustain market leadershipWeekly Gains Report & Safe Capital Investment Plans - DonanımHaber
Can Evogene Ltd. stock sustain free cash flow growth2025 Price Momentum & Entry and Exit Point Strategies - DonanımHaber
Should I hold or sell Evogene Ltd. stock in 20252025 Volume Leaders & Technical Buy Zone Confirmation - Улправда
Will Evogene Ltd. stock keep outperforming rivalsWeekly Stock Recap & Growth Focused Investment Plans - Улправда
Reviewing Vera Therapeutics (NASDAQ:VERA) & Evogene (NASDAQ:EVGN) - Defense World
Will Introduced Innovation Sustain VLS Finance Limiteds GrowthInterest Rate Changes & Superior Trading Strategies - earlytimes.in
Investment Recap: Is Evogene Ltd stock a smart buy before Fed meetingTrade Entry Report & Free Growth Oriented Trading Recommendations - BỘ NỘI VỤ
Evogene (NASDAQ:EVGN) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
How AI Is Breaking Down the Bottlenecks in Small Molecule Drug Discovery - Unite.AI
Evogene (EVGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Sahm
Evogene (NASDAQ:EVGN) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL (PR Newswire) - Aktiellt
Evogene shares climb 5% as cost reductions help deliver earnings beat - MSN
Evogene Ltd. Reports Strategic Shift and Financial Results - MSN
Evogene Ltd. Earnings Call: Strategic Shifts and Optimism - The Globe and Mail
Is Evogene Ltd. stock cheap compared to fundamentals - newser.com
Evogene Ltd. (NASDAQ:EVGN) Q3 2025 Earnings Call Transcript - Insider Monkey
Can Evogene Ltd. stock hit record highs again2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
Is Evogene Ltd. stock oversold or undervalued2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
Evogene: Q3 Earnings Snapshot - Stamford Advocate
Evogene earnings beat by $0.12, revenue fell short of estimates - Investing.com Australia
Evogene Q3 2025 Earnings Call Transcript - MarketBeat
Earnings Call Summary | Evogene(EVGN.US) Q3 2025 Earnings Conference - 富途牛牛
Earnings call transcript: Evogene reports Q3 2025 earnings beat amid restructuring - Investing.com India
Evogene Ltd (EVGN) 財務データ
収益
当期純利益
現金流量
EPS
1.45%
大文字化:
|
ボリューム (24 時間):